These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

908 related items for PubMed ID: 31847896

  • 1. High-sensitivity troponin I and B-type natriuretic peptide biomarkers for prediction of cardiovascular events in patients with coronary artery disease with and without diabetes mellitus.
    Wong YK, Cheung CYY, Tang CS, Hai JSH, Lee CH, Lau KK, Au KW, Cheung BMY, Sham PC, Xu A, Lam KSL, Tse HF.
    Cardiovasc Diabetol; 2019 Dec 17; 18(1):171. PubMed ID: 31847896
    [Abstract] [Full Text] [Related]

  • 2. Prognostic implications of statin intolerance in stable coronary artery disease patients with different levels of high-sensitive troponin.
    Hai JJ, Wong YK, Wong CK, Un KC, Chan PH, Siu CW, Yiu KH, Lau CP, Tse HF.
    BMC Cardiovasc Disord; 2019 Jul 15; 19(1):168. PubMed ID: 31307391
    [Abstract] [Full Text] [Related]

  • 3. Predictive value of visit-to-visit blood pressure variability for cardiovascular events in patients with coronary artery disease with and without diabetes mellitus.
    Wong YK, Chan YH, Hai JSH, Lau KK, Tse HF.
    Cardiovasc Diabetol; 2021 Apr 24; 20(1):88. PubMed ID: 33894788
    [Abstract] [Full Text] [Related]

  • 4. Predictive value of high-sensitivity troponin-I for future adverse cardiovascular outcome in stable patients with type 2 diabetes mellitus.
    Yiu KH, Lau KK, Zhao CT, Chan YH, Chen Y, Zhen Z, Wong A, Lau CP, Tse HF.
    Cardiovasc Diabetol; 2014 Mar 25; 13():63. PubMed ID: 24661773
    [Abstract] [Full Text] [Related]

  • 5. Prognostic value of soluble suppression of tumorigenesis-2 (sST2) for cardiovascular events in coronary artery disease patients with and without diabetes mellitus.
    Li M, Duan L, Cai Y, Hao B, Chen J, Li H, Liu H.
    Cardiovasc Diabetol; 2021 Feb 19; 20(1):49. PubMed ID: 33608010
    [Abstract] [Full Text] [Related]

  • 6. Risk stratification in stable coronary artery disease is possible at cardiac troponin levels below conventional detection and is improved by use of N-terminal pro-B-type natriuretic peptide.
    Lyngbæk S, Winkel P, Gøtze JP, Kastrup J, Gluud C, Kolmos HJ, Kjøller E, Jensen GB, Hansen JF, Hildebrandt P, Hilden J, CLARICOR Trial Group.
    Eur J Prev Cardiol; 2014 Oct 19; 21(10):1275-84. PubMed ID: 23723326
    [Abstract] [Full Text] [Related]

  • 7. Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus.
    Wolsk E, Claggett B, Pfeffer MA, Diaz R, Dickstein K, Gerstein HC, Lawson FC, Lewis EF, Maggioni AP, McMurray JJV, Probstfield JL, Riddle MC, Solomon SD, Tardif JC, Køber L.
    J Am Heart Assoc; 2017 May 29; 6(6):. PubMed ID: 28554908
    [Abstract] [Full Text] [Related]

  • 8. A preliminary report on the prognostic significance of preoperative brain natriuretic peptide and postoperative cardiac troponin in patients undergoing major vascular surgery.
    Bolliger D, Seeberger MD, Lurati Buse GA, Christen P, Rupinski B, Gürke L, Filipovic M.
    Anesth Analg; 2009 Apr 29; 108(4):1069-75. PubMed ID: 19299763
    [Abstract] [Full Text] [Related]

  • 9. Interrelationship in the prognostic efficacy of regional coronary flow reserve, fractional flow reserve, high-sensitivity cardiac troponin-I and NT-proBNP in patients with stable coronary artery disease.
    Hamaya R, Yonetsu T, Kanaji Y, Usui E, Hoshino M, Hada M, Kanno Y, Murai T, Lee T, Kakuta T.
    Heart Vessels; 2019 Mar 29; 34(3):410-418. PubMed ID: 30229410
    [Abstract] [Full Text] [Related]

  • 10. B-Type Natriuretic Peptide and Cardiac Troponin I Are Associated With Adverse Outcomes in Stable Kidney Transplant Recipients.
    Jarolim P, Claggett BL, Conrad MJ, Carpenter MA, Ivanova A, Bostom AG, Kusek JW, Hunsicker LG, Jacques PF, Gravens-Mueller L, Finn P, Solomon SD, Weiner DE, Levey AS, Pfeffer MA.
    Transplantation; 2017 Jan 29; 101(1):182-190. PubMed ID: 26910333
    [Abstract] [Full Text] [Related]

  • 11. Combining high-sensitivity cardiac troponin and B-type natriuretic peptide in the detection of inducible myocardial ischemia.
    Puelacher C, Wagener M, Honegger U, Assadian M, Schaerli N, Mueller D, Strebel I, Twerenbold R, Boeddinghaus J, Nestelberger T, Wildi K, Sabti Z, Sazgary L, Badertscher P, du Fay de Lavallaz J, Marbot S, Kaiser C, Wild D, Zellweger MJ, Reichlin T, Mueller C.
    Clin Biochem; 2018 Feb 29; 52():33-40. PubMed ID: 29107010
    [Abstract] [Full Text] [Related]

  • 12. Age-Biomarkers-Clinical Risk Factors for Prediction of Cardiovascular Events in Patients With Coronary Artery Disease.
    Wong YK, Cheung CYY, Tang CS, Au KW, Hai JSH, Lee CH, Lau KK, Cheung BMY, Sham PC, Xu A, Lam KSL, Tse HF.
    Arterioscler Thromb Vasc Biol; 2018 Oct 29; 38(10):2519-2527. PubMed ID: 30354221
    [Abstract] [Full Text] [Related]

  • 13. Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease.
    Omland T, Pfeffer MA, Solomon SD, de Lemos JA, Røsjø H, Šaltytė Benth J, Maggioni A, Domanski MJ, Rouleau JL, Sabatine MS, Braunwald E, PEACE Investigators.
    J Am Coll Cardiol; 2013 Mar 26; 61(12):1240-9. PubMed ID: 23414791
    [Abstract] [Full Text] [Related]

  • 14. Targeted multiple biomarker approach in predicting cardiovascular events in patients with diabetes.
    Resl M, Clodi M, Vila G, Luger A, Neuhold S, Wurm R, Adlbrecht C, Strunk G, Fritzer-Szekeres M, Prager R, Pacher R, Hülsmann M.
    Heart; 2016 Dec 15; 102(24):1963-1968. PubMed ID: 27456261
    [Abstract] [Full Text] [Related]

  • 15. Apolipoprotein CIII and N-terminal prohormone b-type natriuretic peptide as independent predictors for cardiovascular disease in type 2 diabetes.
    Colombo M, Looker HC, Farran B, Agakov F, Brosnan MJ, Welsh P, Sattar N, Livingstone S, Durrington PN, Betteridge DJ, McKeigue PM, Colhoun HM.
    Atherosclerosis; 2018 Jul 15; 274():182-190. PubMed ID: 29793175
    [Abstract] [Full Text] [Related]

  • 16. Incremental value of B-type natriuretic peptide for detection and risk reclassification of obstructive coronary artery disease on computed tomography angiography.
    Kawabe M, Sato A, Hoshi T, Endo M, Yoshida I, Aonuma K.
    J Cardiol; 2017 Apr 15; 69(4):671-677. PubMed ID: 27443597
    [Abstract] [Full Text] [Related]

  • 17. B-Type Natriuretic Peptide Assessment in Patients Undergoing Revascularization for Left Main Coronary Artery Disease: Analysis From the EXCEL Trial.
    Redfors B, Chen S, Crowley A, Ben-Yehuda O, Gersh BJ, Lembo NJ, Brown WM, Banning AP, Taggart DP, Serruys PW, Kappetein AP, Sabik JF, Stone GW.
    Circulation; 2018 Jul 31; 138(5):469-478. PubMed ID: 29666071
    [Abstract] [Full Text] [Related]

  • 18. The Impact of Biochemical Markers on Major Adverse Cardiovascular Events and Contralateral Carotid Artery Stenosis Progression Following Carotid Interventions.
    Stone PA, Thompson SN, Khan M, Northfield E, Schillinger R, Skaff P.
    Ann Vasc Surg; 2017 Jan 31; 38():144-150. PubMed ID: 27546852
    [Abstract] [Full Text] [Related]

  • 19. Joint effects of N-terminal pro-B-type-natriuretic peptide and C-reactive protein vs angiographic severity in predicting major adverse cardiovascular events and clinical restenosis after coronary angioplasty in patients with stable coronary artery disease.
    Dai DF, Hwang JJ, Lin JL, Lin JW, Hsu CN, Lin CM, Chiang FT, Lai LP, Hsu KL, Tseng CD, Tseng YZ.
    Circ J; 2008 Aug 31; 72(8):1316-23. PubMed ID: 18654020
    [Abstract] [Full Text] [Related]

  • 20. Effect Modification of Chronic Kidney Disease on the Association of Circulating and Imaging Cardiac Biomarkers With Outcomes.
    Gregg LP, Adams-Huet B, Li X, Colbert G, Jain N, de Lemos JA, Hedayati SS.
    J Am Heart Assoc; 2017 Jul 05; 6(7):. PubMed ID: 28679558
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.